See the Interprac as very complimentary to SEQ but getting economies of scale is always a risk paying a higher multiple but even with a larger script anything around current SP offers plenty of upside when acquisition is bedded down, not to mention helping the terrible liquidity.
Ann: Appendix 4C - quarterly, page-43
Add SEQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
0.010(2.15%) |
Mkt cap ! $59.17M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 49.0¢ | 46.5¢ | $355.5K | 750.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11467 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 93412 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| SEQ (ASX) Chart |